AlphaCore Capital »

Vertex Pharmaceuticals Incorporated shares owned by AlphaCore Capital

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by AlphaCore Capital from 13F filings

Historical chart of AlphaCore Capital investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by AlphaCore Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by AlphaCore Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.1M 5.3k 391.64
2025-06-30 $2.2M 5.0k 445.20
2025-03-31 $475k 979 484.84
2024-12-31 $374k 928 402.70
2024-09-30 $442k 950 465.08
2024-06-30 $444k 948 468.72

More positions owned by AlphaCore Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Meta Platforms Cl A (META)
Schwab Strategic Tr Fundamental Us L (FNDX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
MPLX Com Unit Rep Ltd (MPLX)
Schwab Strategic Tr Fundamental Intl (FNDF)
Ishares Tr Core Msci Total (IXUS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Etf Ser Solutions Distillate Us (DSTL)
Ishares Tr Russell 3000 Etf (IWV)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)

View all positions for AlphaCore Capital

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated